Chief Medical Officer · Mirum Pharmaceuticals, Inc. · Mirum Pharmaceuticals, Inc. — Restricted Stock Units
Side
A
Value
—
Shares
25.0K
Price
—
Executed
Oct 9, 2026
Disclosed
Oct 14, 2026
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Oct 9 executedOct 14, 2026 disclosed
MIRM · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+6 / 15
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Mirum Pharmaceuticals, Inc. — Restricted Stock Units
Ticker
MIRM
Shares
25.0K
Price per share
$0
Execution date (reported)
Oct 9, 2026
Owned after transaction
25.0K shares
Days from execution to publication
5
What this establishes
Myers Robert Paul filed this Form 4 reporting a grant or award of MIRM on Oct 9, 2026. It became public on Oct 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Medical Officer
Myers Robert Paulcik:0002155916
Issuer
Mirum Pharmaceuticals, Inc.cik:0001759425
Revision history · 0
No field has changed since this record was first ingested.
